|
|
|
|
|
|
|
Comprehensive
intelligence on over 8,500 drugs in active R&D
|
|
|
|
|
|
|
The premier service for monitoring
the development, efficacy and status of pharmaceuticals from
early clinical testing through to launch.
|
|
|
|
|
Data is gathered through direct
contact with manufacturers and research organisations. It
appraises both the scientific and commercial aspects of drug
development.
Searchable:
|
|
by product - what's going on
with the development of brand X?
|
|
|
by company - what is corporation
Y getting in to, how strong is their pipeline?
|
|
|
by phase - what can we expect
to see coming to market in 10 years?
|
|
|
by mechanism of action - what drug technologies
are becoming significant?
|
|
|
by country - what drugs are
being developed for licensing in Japan?
|
|
|
|
|
|
Keep up to date with competitor
activity, identify important emerging therapy areas, target
partners for joint ventures and licensing or assess R&D
portfolios for investment and acquisition purposes.
|
|
|
|
|
|
For
prices contact IMS Health
|
Available on CD ROM or web . Other licenses available. Download
a Self-running demonstration.
Request further information |
|
|
|
